 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Research > MediChem Life Sciences, Inc.
 |
MediChem Life Sciences, Inc. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
MediChem expects lowered second-quarter results Jul 17 2001 04:48 PM PDT
> More WIRE STORIES about this company
PROFILE |
 |
Need a guy in a white lab coat? MediChem Life Sciences and subsidiaries Emerald BioStructures and ThermoGen offer R&D chemistry services to biotechnology (49% of sales) and pharmaceutical (43%) firms. Services include proteomics (protein mapping, primarily through Emerald BioStructures), the creation of customized compound libraries, chemical process development, and even chemistry project teams (white coats optional). ThermoGen offers enzyme catalyst services, while affiliate Advanced Life Sciences oversees the firm's own drug development. MediChem sells the majority of its services in the US, but it continues to expand its services in Europe and Asia. Chairman and CEO Michael Flavin owns 30% of the company.
COMPETITION |
 |
Albany Molecular Research, Inc. (AMRI)
Array BioPharma Inc. (ARRY)
Discovery Partners International, Inc. (DPII)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 19.40
1-Yr. Sales Growth: 26.4%
Employees: 217
Revenue per employee: $89,400.92
KEY PEOPLE |
 |
Michael T. Flavin
CEO
R. Richard Wieland
CFO
CONTACT INFO |
 |
2501 Davey Rd.
Woodridge, IL 60517
US
Phone: 630-783-4600
Fax: 630-783-4705
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |